Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Lixisenatide adlyxin fda approval status?
Tafamidis meglumine price?
What's the frequency of polivy's main side effects?
Cresemba 100 mg price in pakistan?
Alclometasone shortage?

Can you name the specific year keytruda gained initial fda approval for cancer care?

See the DrugPatentWatch profile for keytruda

Keytruda, also known as pembrolizumab, is a medication developed by Merck for the treatment of cancer. Keytruda gained initial FDA approval for cancer care in the year 2014.

According to DrugPatentWatch.com, the FDA approved Keytruda (pembrolizumab) for use in unresectable or metastatic melanoma on September 4, 2014 [1]. At the time, this was the first approval for a PD-1 checkpoint inhibitor.

Since then, Keytruda has received several more approvals for various types of cancer, solidifying its position as a key treatment option for patients with advanced cancer.

Sources:
[1] https://www.drugpatentwatch.com/patents/US-D646-001-USA-PATENT (DrugPatentWatch.com)



Other Questions About Keytruda :

Which corporation is responsible for keytruda's patent? Can keytruda's side effects worsen over time? How can keytruda's side effects be managed during breast cancer therapy? What is the fda approval year for keytruda in lung cancer therapy? Which patients should avoid keytruda with organ issues? In what year did keytruda receive initial fda approval for cancer treatment? Are there any patient assistance programs for keytruda's cost?